Member Info for ahha

Why is it that with reference to the recent share trades recorded on this site .........there are always far more buys than sells in Huntsworth.......and every evidence that the shares are are tightly held and believed in by the Directors [ judging by the evidence of consistent Director buying as shown in the record on this site]....why why why can the shares fall from 75p to 33p! And WHY has the price of the shares fallen from 44p to 41p after the purchase of 1.6 million shares yesterday?!!!!! Why did the shares jump, after no recorded buying from 33p to 43p last week? Ok.....I know there was a positive statement from the company....but if Market Makers can just increase the price of shares or decrease them just at whim, irrespective of the support for the shares or their success as a company....then how can anyone have any faith whatsoever in shares or the statitics that provide a rationale for buying them?!! And where does the value go after a price has just been halved overnight? None of the books I have read on inverstment seem to answer this question. Is it forbidden knowledge/ A trade secret? Can someone explain please?

The Directors are buying again.......I don't think they seem to be too worried about 'concerns for top-line growth'

thanks for the feedback.......sometimes it's a bit lonely being an investor.....especially on shares that have little news or comment from others........in the light of your encouraging remarks, it might be worth getting a few hundred thousand more,asyou say .......at least I can enjoy the dividend! I don't know if you were ever invested in Highway Insurance........but I made a pretty penny on those! But it was after a long wait.....and the shares seemed to tread water forever and falling slightly, before suddenly leaping 33% at takeover news.

looks like the price is rising again. I've been holding these shares for six years at leastIhave enjoyed the nice dividend and fairly stable share price...and have been waiting like a Komodo Dragon.......but the unfortunate disasters in New Zealand and Japan has muddied the waters. Is the company still attractive as at takeover target? Your opinions would be welcomed.

I have held these shares for around10 years........they do not pay dividends, but I have remained a loyal investor in the hope that I would get a major gain as a result of Varasolve being brought to market....it has been a very long wait. Of late, these shares seem to be very boring, they just seem to go no where! My patience is running out.......however, I did read the following the other day on the Interavtive Investor message board .......so maybe it might be worth holding for a few more years! The men fromthe Pru ought toknowagoodthing when they see it. Prudential. But what is certain, is that the Pru realised the SP would be forced down (both by shorters and biocompatibles sellers). So the Pru is mopping up on the downside. They know as we should, that there are not so much shares left with smaller investors. Perhaps only about 20%. Invesco is probably not going to sell before a major deal, but they won’t buy more than 29% either. Almost all the other major holders increased their holding since November 2010 : Prudential, AXA, Schroders, Hunter Hall etc. Make the sum off all these and you will see that there is not much left ‘on the market’. One day in the near future it will rapidly become difficult to get BTG shares. SP will go up seriously. The slightest news about the BTG pipeline could trigger this most probable and important rise. Ambiorix. Does anyone else out there have any views on this share?

Ex-div: 25 May Payment: 6 Jul *Includes intangible assets of £291.9m, or 119p a share

Investors Chronicle SpikeyDT View Author's profile | Add to favourites | Ignore | Author's posts Subscription im happy sharing with the forum; Huntsworth's reshaping bears fruit Created: 23 March 2011 Written by: Malar Velaigam Public relations specialist Huntsworth had a tough year - it lost £2m in fees due to public sector spending cuts. But exposure to this sector is now minimal and chief executive Peter Chadlington says 72 per cent of 2011's revenues are already committed. Having reshaped the business to become more global, Huntsworth won three big deals - including one with British Airways. Indeed, such global clients now account for 44 per cent of revenues, with four global clients now paying fees of over £3m. Average fees per client have also increased 18 per cent to £69,000. A new focus on larger, global deals, for longer durations, means deals will take longer to generate revenues. So Mr Chadlington warns that fees will be second-half weighted - but he expects organic revenue growth of at least 7 per cent this year; organic sales fell 0.7 per cent in 2010. On a divisional level, Huntsworth Health's sales rose 3.3 per cent to £51.4m, while sales at niche PR business Red remained stable at £12.9m. That helped offset weaker performances from Cititgate and Grayling, where revenues contracted 4.2 per cent and 2 per cent to £26.3m and £83.2m, respectively. Broker Peel Hunt expects adjusted pre-tax profit of £20m for 2011, giving EPS of 9p. HUNTSWORTH (HNT) ORD PRICE: 72p MARKET VALUE: £176.2m TOUCH: 71-72p 12-MONTH HIGH: 89p LOW:65p DIVIDEND YIELD: 4.9% PE RATIO: 10 NET ASSET VALUE: 84p* NET DEBT: 26% Year to 31 Dec Turnover (£m) Pre-tax profit (£m) Earnings per share (p) Dividend per share (p) 2006 140 4.0 1.5 1.9 2007 152 10.8 5.9 2.5 2008 159 20.1 4.8 2.7 2009 209 -10.0 -4.2 2.9 2010 224 21.8 7.4 3.5 % change +7 -319 -276 +21 Ex-div: 25 May Payment: 6 Jul *Includes intangible assets of £291.9m, or 119p a share More analysis of company results More share tips and updates... TIP UPDATE Buy Huntsworth looks in better shape and there's a tasty yield. The shares are up on our buy tip (65p, 11 Dec 200965p, 11 Dec 2009) but, trading on an undemanding eight times expected earnings, we reiterate that advice. Buy. Last IC view: Buy, 74.5p, 19 Nov 2010

Nearly 100% upside also: http://tradertrouble.co.uk/broker-recommendations/broker-recommendations-11-january-2010.html -------------------------------------------------------------------------------- 12-12-09 Investors Chronicle - Buy Reccommendation... ERB2008 2 Huntsworth armed for the upturn Created: 11 December 2009 Written by: Malar Velaigam BULL POINTS: ■ Acquisition-driven growth ■ Resilient client base ■ High level of committed revenues ■ Rationalisation to boost organic growth BEAR POINTS: ■ Exceptional costs in 2009 ■ Some clients in vulnerable sectors Advertising Last week, public relations (PR) specialists Huntsworth announced yet another acquisition as the group - which is led by the founder of Shandwick PR, Peter Gummer (now Lord Chadlington) - continues its push to become a global PR player. The £20m deal was with Washington-based Dutko Worldwide, which has 10 offices in the US and claims to be the largest independent public policy management firm - better known as a lobbyist - in the US. The purchase significantly bolsters Huntsworth's lobbyist network, which activity currently accounts for about 7 per cent of Huntsworth's revenues. Moreover, Malcolm Morgan, an analyst at stockbroker KBC Peel Hunt, expects it will add to earnings by next year. The deal will also add to Huntsworth's growing US presence, which accounted for 26 per cent of revenues in its last financial year. This is also Huntsworth's third acquisition this year. The group purchased Middle East-based PR outfit Momentum International in February; UK and US PR company Tonic Life Communications in July and Swedish PR business Sund Kommunikation i Malmo in August. Huntsworth also made an approach for Aim-quoted technology PR group Next Fifteen in May, although this was rejected. So far, integrating acquisitions has not appeared to be a problem, and Huntsworth has now made more than 20 since 2003. Indeed, its bosses are keen to buy in more growth. However, this does not mean they have given up on organic growth. The hope is that this will be achieved via a rationalisation programme, which has seen Huntsworth consolidate its 26 brands into just four. These four divisions will be Huntsworth Healthcare, Citigate, Grayling and Red. Grayling, will house a number of brands, including Trimedia and Mmd, and will account for 44 per cent of group revenues. The streamlining, which was announced less than a year ago, has been completed ahead of schedule and management is confident it will help boost organic growth from 2011 onwards. This will, however, mean a one-off exceptional charge.

19 November 2010 Huntsworth plc ("Huntsworth" or "the Group") Interim Management Statement Increased confidence of growth in 2011 Success in attracting global clients Changes to Group Board IMS Statement Huntsworth plc, the global public relations and healthcare communications group, announces that it is trading in line with management profit and earnings expectations for 2010. The Group has excellent margins both before and after central costs and a strong new business book running well into 2011 with about 65% of 2011 revenues already committed. The Group has concentrated on using its new streamlined organisation to pitch for global and multi-office accounts in 2010. This strategy is bearing fruit and the Group has a very strong pipeline of international and global pitches, including our largest PR opportunity to date, which we expect to come on stream during the first quarter of 2011 and run for a number of years. Contract negotiations for these larger international clients take several months and some revenue has moved from 2010 into next year. We therefore expect 2010 revenues to be below management's expectations but have renewed confidence that 2011 management revenue and profit expectations will be met. The balance sheet remains robust with net debt comfortably within banking covenants. CITIGATE Citigate, which is 15% of the Group, has won a number of new retained mandates including Hyder Consulting PLC and Oando PLC. Recent transactions include United Business Media's $287m acquisition of Canon Communications LLC, Palamon Capital Partners LLP's €243m sale of Retail Decisions Ltd's Australian business and the IPO of Argos Resources Ltd. GRAYLING Grayling, which together with Dutko our public affairs business in Washington represents 49% of Group revenues, is seeing real momentum in pitching for, and winning, larger clients. The bulk of these wins will be worked on in 2011 and beyond. Significant international wins include Volkswagen Middle East and Hilton Worldwide. HUNTSWORTH HEALTH Huntsworth Health, which is 29% of the Group, continues to gain in strength and reputation. We continued to build on our global structure which provided the rationale for Huntsworth Health to become a preferred provider in 14 different companies and the division is well placed to leverage this status in 2011. Digital revenues in particular continue to grow strongly.

What is going on with this share? One of the largest buys for days in very thin trade and the result? A drop in the share price! Something strange going on with this share.....can anyone explain?

Pamure Gordon has £1.00 price target on this share.........and there are predictions of at least 7% growth next year with new business in India and China etc. Someone bought 500,000 shares yesterday....hmmmmmm......looks good!

Can someone explain? This share seems to be hardly traded........on a daily basis.....but on the 7th Dec about a million shares were sold . Why did't the price go down? Makes me wonder just how significant all these trading figures rerally are. The the PE ratio -17.32 what does this mean? Iunderstoodthat the lower the P/E the better....but what doesit mean when the figureis below 1? And if these sharesareso unloved and boring......why have so many of the directors bought the shares and hold them tightly? About a year ago these shares were tipped in the Telegraph as a strong buy. Now no one seems to be interested But I have learned from expereince that a share that does nothing for a long time is usually ripe for buying and about to spring to life dramatically......well at least that's my hope! Does anyone else share my view?

What are the views on this mornings news? I guess it's ok long term........but I've been holding these shares for years and their performance is lacklusture....bit like watching paint dry! The varasolve saga goes on and on...we've been waiting for years and years for that to come to market and now we are told another three years to wait.....and I bet that will eventually disappoint. Any views on where the share priceis heading short term?

Is there anyone out there who holds these shares? I believe in this company and so do the directors. But hardly anyone seems to trade these shares......and they seem to be safe but dull! It's like watching paint dry. Does anyone have any comments?

£4.50 here we come!!!!!! More news on Varasolve to follow!!!

Is there anyone out there who can give me some encouragement.....I'm worried about the next few months......not sure whether to take a profit.....got in at 90p.......but i don't want to miss out on further gains. Does anyone have any thoughts? I was told the last three weeks of May should be a time to sell. Ahha

Why has all the chat about Alyzyme dried up? I hold 30,000 I need some reassurance......come on guys lets have some encouragement! Someone is buying....250,000 before today's close [ 6th May ] How long do we have to wait for a recovery? Ahha

Tom Winnifrith has tipped this one, last week, to go to £1.33 short term......and £2.00 before end of year! I've been following this company ever since he first tipped it on TV 8 years ago,when he said it could get to £20.00. How things in the stock market change. Any how......I'm wondering if there will be a pullback and another buying opportunity,before it moves forward again. How long do folks think it will take to get finall approval for Varisolve? It's got to be another 18 months surely? The price will really start to liven up then! Any thoughts?

Some very large buys and huge turnover in AZM today....what's going on?